2023
DOI: 10.1186/s12894-023-01216-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort

Abstract: Background Clear cell papillary renal cell tumor (CCPRCT) was first reported in 2006 a patient with end stage renal disease. After that it was discovered in the kidney without end stage renal disease in the 2010s and started to be mentioned in pathology and urology. The incidence of CCPRCT is low and most of it is discovered incidentally, so there is a lack of reports on clinical characteristics and surgical outcome. Methods This study used clinica… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Focal calcifications can be seen, but round, concentrically layered, psammomatous calcifications have never been reported. The prevalence of CCPRCT, like MCNLMP, is between 1% and 4% 26,27 with no recurrences, metastasis, or cancer specific mortality in cases with typical histopathology features. Genetically, these tumors lack the key cytogenetic alterations of papillary renal cell carcinoma (trisomy 7 and 17) and ccRCC (abnormalities of the VHL gene and losses of chromosomal material from 3p25); however, a specific genetic signature remains unknown.…”
Section: Case Reportmentioning
confidence: 99%
“…Focal calcifications can be seen, but round, concentrically layered, psammomatous calcifications have never been reported. The prevalence of CCPRCT, like MCNLMP, is between 1% and 4% 26,27 with no recurrences, metastasis, or cancer specific mortality in cases with typical histopathology features. Genetically, these tumors lack the key cytogenetic alterations of papillary renal cell carcinoma (trisomy 7 and 17) and ccRCC (abnormalities of the VHL gene and losses of chromosomal material from 3p25); however, a specific genetic signature remains unknown.…”
Section: Case Reportmentioning
confidence: 99%